CASI Pharmaceuticals Inc

NASDAQ:CASI  
0.91
-0.03 (-3.63%)
Earnings Announcements

CASI Pharmaceuticals Announces Third Quarter 2021 Financial Results

Published: 11/12/2021 12:36 GMT
CASI Pharmaceuticals Inc (CASI) - Casi Pharmaceuticals Announces Third Quarter 2021 Financial Results.
Q3 Revenue $8.1 Million.
Qtrly Net Loss per Share $0.07.
Q3 Earnings per Share View $-0.06, Revenue View $7.5 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $9.01 Million
Adjusted EPS is expected to be -$0.06

Next Quarter Revenue Guidance is expected to be $9.42 Million
Next Quarter EPS Guidance is expected to be -$0.06

More details on our Analysts Page.